Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels
Authors:
- Devy M. EmperadorDEDevy M. Emperador
- Mars StoneMSMars Stone
- Eduard GrebeEGEduard Grebe
- Camille EscadafalCECamille Escadafal
- Honey DaveHDHoney Dave
- Eve LackritzELEve Lackritz
- Cassandra Kelly-CirinoCKCassandra Kelly-Cirino
- Ingrid RabeIRIngrid Rabe
- Diana P. RojasDRDiana P. Rojas
- Michael P. BuschMBMichael P. Busch
- Graham SimmonsGSGraham Simmons
Open Access
Abstract
In response to the 2015 Zika virus (ZIKV) epidemic that occurred in Brazil, numerous commercial serological assays have been developed for clinical and research applications. Diagnosis of recent infection in pregnant women remains challenging. Having standardized, comparative studies of ZIKV tests is important for implementing optimal diagnostic testing and disease surveillance. This is especially important for serology tests used to detect ZIKV infection given that antibodies against ZIKV can cross-react with other arboviruses in the same virus family, such as dengue virus (DENV), yellow fever virus (YFV) and West Nile virus (WNV). We looked at the sensitivity and specificity of tests detecting ZIKV antibodies (IgM, IgG) from multiple manufacturers using panels of samples previously collected with known exposure to ZIKV and other arboviruses. We found that performance of the IgM tests was highly variable, with only one test (Inbios 2.0 IgM capture ELISA) having both high sensitivity and specificity. All IgG tests showed good sensitivity; however, specificity was highly variable, with some assays giving false-positive results on samples infected by another flavivirus. Overall, the results confirmed that accurate ZIKV antibody testing is challenging, especially in specimens from regions endemic for multiple other flaviviruses, and highlight the importance of available and suitable reference samples to evaluate ZIKV diagnostics.Keywords
Funding Information
- World Health Organization (RC2HL101632, 200-2014-M-59495, 200-2015-M-81883)
- National Heart, Lung and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III) program (RC2HL101632, 200-2014-M-59495, 200-2015-M-81883)
- Centers for Disease Control and Prevention (RC2HL101632, 200-2014-M-59495, 200-2015-M-81883)
This publication has 22 references indexed in Scilit:
- Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational studyThe Lancet Infectious Diseases, 2020
- Zika Virus Infection — After the PandemicNew England Journal of Medicine, 2019
- Utility of reference materials for Zika Virus nucleic acid testingBiologicals, 2019
- Multi-laboratory comparison of three commercially available Zika IgM enzyme-linked immunosorbent assaysJournal of Virological Methods, 2018
- Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus EpidemicsClinical Infectious Diseases, 2017
- Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionScience, 2016
- Broad and strong: the ultimate antibody to dengue virusNature Immunology, 2015
- Persistence of West Nile Virus-Specific Antibodies in Viremic Blood DonorsClinical and Vaccine Immunology, 2007
- Statistical Methods in Diagnostic Medicine2002